Ingevity Corporation (NYSE:NGVT) today announced that it will
hold a live webinar to review and discuss its Pavement Technologies
business on April 16, 2020, at 10 a.m. (Eastern Time). This is the
first event in a previously announced webinar series that will
serve to educate analysts and investors about its businesses.
Presenters will include Mike Smith, executive vice president and
president, Performance Chemicals, and Andrew Crow, vice president,
Pavement Technologies. Rick Kelson, chairman of the board, and
interim president and CEO; John Fortson, executive vice president,
chief financial officer and treasurer; and Dan Gallagher, vice
president, investor relations, will also be available for
questions.
The Pavement Technologies webinar will be conducted via webcast
and can be accessed through Ingevity’s Investor Relations site, or
via this link: Ingevity Pavement Technologies webinar.
This event will also be accessible by teleconference by dialing
877-407-2991 (inside the U.S.) or 201-389-0925 (outside the U.S.),
at least 10 minutes prior to the start of the event.
For those unable to join the live event, a replay of the webinar
will be available beginning at approximately 2 p.m. (Eastern Time)
on April 16, 2020, through May 16, 2020, at: Ingevity Pavement
Technologies webinar replay.
Information on how to access the webinar and teleconference,
along with a slide deck containing other relevant business
information, will be posted to the investors section of Ingevity’s
website at www.ingevity.com prior to the call.
For a full list of upcoming webinars in this series, please see
the press release issued by Ingevity on March 24, 2020.
Ingevity: Purify, Protect and Enhance
Ingevity provides specialty chemicals, high-performance carbon
materials and engineered polymers that purify, protect and enhance
the world around us. Through a team of talented and experienced
people, Ingevity develops, manufactures, and brings to market
products and processes that help customers solve complex problems.
These products are used in a variety of demanding applications,
including asphalt paving, oil exploration and production,
agrochemicals, adhesives, lubricants, publication inks, coatings,
elastomers, bioplastics and automotive components that reduce
gasoline vapor emissions. Headquartered in North Charleston, South
Carolina, Ingevity operates from 25 locations around the world and
employs approximately 1,850 people. The company is traded on the
New York Stock Exchange (NYSE: NGVT). For more information visit
www.ingevity.com.
Forward-Looking Statements
This press release contains “forward-looking statements” within
the meaning of the Securities Exchange Act of 1934, as amended, and
the Private Securities Litigation Reform Act of 1995. Such forward
looking statements generally include the words “may,” “could,”
“should,” “believes,” “plans,” “intends,” “targets,” “will,”
“expects,” “suggests,” “anticipates,” “outlook,” “continues,”
“forecast,” “prospect,” “potential” or similar expressions.
Forward-looking statements may include, without limitation,
expected financial positions, results of operations and cash flows;
financing plans; business strategies and expectations; operating
plans; impact of coronavirus; synergies and the potential benefits
of the acquisition of Perstorp Holding AB’s Capa caprolactone
business (the “acquisition”); capital and other expenditures;
competitive positions; growth opportunities for existing products;
benefits from new technology and cost-reduction initiatives, plans
and objectives; markets for securities and expected future
repurchases of shares, including statements about the manner,
amount and timing of repurchases. Like other businesses, Ingevity
is subject to risks and uncertainties that could cause its actual
results to differ materially from its expectations or that could
cause other forward-looking statements to prove incorrect. Factors
that could cause actual results to materially differ from those
contained in the forward-looking statements, or that could cause
other forward-looking statements to prove incorrect, include,
without limitation, risks that the expected benefits from the
acquisition will not be realized or will not be realized in the
expected time period; the risk that the acquired business will not
be integrated successfully; significant transaction costs; unknown
or understated liabilities; general economic and financial
conditions; international sales and operations; currency exchange
rates and currency devaluation; compliance with U.S. and foreign
regulations; competition from infringing intellectual property
activity; attracting and retaining key personnel; changes in trade
policy, including the imposition of tariffs; the impact of the
United Kingdom’s withdrawal from the European Union; conditions in
the automotive market or adoption of alternative technologies;
worldwide air quality standards; a decrease in government
infrastructure spending; declining volumes and downward pricing in
the printing inks market; the limited supply of crude tall oil
(“CTO”); lack of access to sufficient CTO; access to and pricing of
raw materials; competition from producers of alternative products
and new technologies, and new or emerging competitors; a prolonged
period of low energy prices; the provision of services by third
parties at several facilities; natural disasters, such as
hurricanes, winter or tropical storms, earthquakes, floods, fires;
the adverse effect of the coronavirus on our global sales and
operations, demand for our automotive carbon products, and our
manufacturing facilities and supply chain; other unanticipated
problems such as labor difficulties including renewal of collective
bargaining agreements, equipment failure or unscheduled maintenance
and repair; protection of intellectual property and proprietary
information; information technology security breaches and other
disruptions; government policies and regulations, including, but
not limited to, those affecting the environment, climate change,
tax policies, tariffs and the chemicals industry; and lawsuits
arising out of environmental damage or personal injuries associated
with chemical or other manufacturing processes. These and other
important factors that could cause actual results or events to
differ materially from those expressed in forward-looking
statements that may have been made in this document are and will be
more particularly described in our filings with the U.S. Securities
and Exchange Commission, including our Form 10-K for the year ended
December 31, 2019 and our other periodic filings. Readers are
cautioned not to place undue reliance on Ingevity’s projections and
forward-looking statements, which speak only as the date thereof.
Ingevity undertakes no obligation to publicly release any revision
to the projections and forward-looking statements contained in this
press release, or to update them to reflect events or circumstances
occurring after the date of this announcement.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200402005113/en/
Laura Woodcock
843-746-8197 laura.woodcock@ingevity.com
Investors: Dan
Gallagher 843-740-2126 daniel.gallagher@ingevity.com
Ingevity (NYSE:NGVT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ingevity (NYSE:NGVT)
Historical Stock Chart
From Apr 2023 to Apr 2024